Capricor Therapeutics (FRA:4LN2) 3-Year Revenue Growth Rate : 260.90% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Capricor Therapeutics 3-Year Revenue Growth Rate?

Capricor Therapeutics's Revenue per Share for the three months ended in Mar. 2024 was €0.14.

During the past 12 months, Capricor Therapeutics's average Revenue per Share Growth Rate was 328.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 260.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was -2.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Capricor Therapeutics was 260.90% per year. The lowest was -73.10% per year. And the median was -37.90% per year.

Competitive Comparison of Capricor Therapeutics's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Capricor Therapeutics's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Capricor Therapeutics's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Capricor Therapeutics's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Capricor Therapeutics's 3-Year Revenue Growth Rate falls into.

Capricor Therapeutics 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Capricor Therapeutics (FRA:4LN2) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Capricor Therapeutics 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Capricor Therapeutics's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Capricor Therapeutics (FRA:4LN2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Capricor Therapeutics Inc (FRA:4LN2) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

CAPR:USA

Address

10865 Road to the Cure, Suite 150, San Diego, CA, USA, 92121

Website

https://www.capricor.com

Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.

Capricor Therapeutics (FRA:4LN2) Headlines

No Headlines